The U.S. Food and Drug Administration today granted accelerated approval to Aliqopa (copanlisib) for the treatment of adults with relapsed follicular lymphoma who have received at least two prior treatments known as systemic therapies.
from Food and Drug Administration--Press Releases http://ift.tt/2wsjx0t
via IFTTT
No comments:
Post a Comment